The latest gastro-intestinal cancer news
Pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer
Initial findings of the phase III KEYNOTE-811 trial of pembrolizumab plus trastuzumab and chemotherapy -…
The latest gastro-intestinal cancer news
Initial findings of the phase III KEYNOTE-811 trial of pembrolizumab plus trastuzumab and chemotherapy -…
Professor Niall Tebbutt has been awarded the Gastric Cancer Research Grant (including Linitis Plastica) to…
There are still no established biomarkers to predict the success of immunotherapy in patients with…
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC),…
The new research findings help to understand mechanisms that lead to different types of intestinal…
A study published in the journal Cell Host & Microbe reported that the increased presence of…
Neuroendocrine cancer can manifest itself as many small tumours in a cluster in the small…
Even though young patients with metastatic colorectal cancer tend to be more fit and receive…
A new study from the Slone Epidemiology Center and the Boston University School of Medicine,…
Cancerous tumours are made up of many more components than just malignant cells from the…